Aims: To describe the demographics of the paediatric RRT population under the age of 16 years in the UK and to analyse changes in demography with time. Methods: Extraction and analysis of data from the UK Renal Registry (UKRR). Results: There were 751 children <16 years old with established renal failure (ERF) in the UK in December 2009. The reported prevalence under the age of 16 years was 65 per million age related population (pmarp) and the reported incidence 9.3 pmarp. The incidence and prevalence for South Asian patients was much higher than that of the White and Black populations. Of the patients for whom a primary renal diagnosis had been reported, renal dysplasiaAEreflux was the most common cause of ERF accounting for 34.0% of prevalent cases. There has been growth in treatment numbers in all paediatric renal centres between 1995 and 2010. Whilst the rate of transplantation within 90 days of commencing RRT has remained at around 25-30% of patients, the use of HD has increased by 4% at the expense of PD. Conclusions: The paediatric ERF population continued to expand with a slow increase in both incidence and prevalence rates. The high incidence in patients from ethnic minority groups will lead to a greater proportion of the population being from these groups in time. To maintain the high proportion of engrafted patients it will be necessary to encourage living donation in the ethnic minority population. 
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Introduction
Established renal failure (ERF) requiring renal replacement therapy (RRT) is a rare but significant cause of long term morbidity and mortality during childhood. In the United Kingdom (UK), the annual incidence of treated ERF has remained stable at between 5 to 10 children per million age related population (pmarp) each year over the past 20-25 years although the prevalence rates have increased steadily to 56.1 pmarp in 2008 [1] . This increase in prevalence is likely to be a result of improved survival of children across the paediatric age range as a result of advances in the delivery of care with more effective dialysis, improved nutrition and the availability of better immunosuppressive medications following renal transplantation.
Accurate evaluation of the demographics of this cohort is important to inform further improvement in delivery of care and to form the basis of well designed research analysis. The objectives of this report are: i) To describe the prevalence, incidence, causes of ERF and modality of treatment of children on RRT in the UK on 31st December 2009 and ii) To describe trends of the same over the past 15 years.
Methods
Data collection took place across the 13 paediatric nephrology centres in the UK that provided care to all children on RRT in 2009. Some centres collected data electronically and submitted this to the UK Renal Registry (UKRR) with the remaining centres reporting data using 'paper-based' data returns. These data were then manually entered into the current paediatric UKRR database.
This year, five centres supplied data on paper returns with the remaining centres providing electronic files that were uploaded directly into the current paediatric UKRR database. Southampton provided an electronic file but due to technical difficulties was only able to send a limited dataset.
In this report patient groups are described as follows: patients who were receiving RRT on the 31st Statistical analyses were performed using SAS 9.2.
Results

Completeness of data returns
The procedures for data collection and processing are still evolving but there was good completion of the core data items as shown in table 5.1.
The UK paediatric prevalent ERF population in 2009
A total of 999 children and young people under 18 with ERF were receiving treatment at paediatric nephrology centres in 2009. At the census date, 67% had a functioning transplant, 15% were receiving peritoneal dialysis (PD) and 9% were receiving haemodialysis (HD). The modality was unknown in a further 9%. As incomplete data was available for the 16-18 year old adolescent patients they have been excluded from these analyses. This report therefore presents data relating to patients less than 16 years of age only.
There were 751 children under 16 years of age receiving RRT in the UK in 2009. Table 5 .2 shows the number of patients receiving RRT by age group and gender plus rate of RRT pmarp. The prevalence of RRT increased with age and was higher in males. The reported prevalence rate in under 16 year olds was 65 pmarp. Table 5 .3 shows the ethnic origin of current RRT patients. Increasing prevalence pmarp was observed with increasing age in all ethnic groups but children from ethnic minorities displayed higher prevalent rates of RRT when compared with White children.
Modality of treatment
Current treatment modality in the prevalent paediatric population less than 16 years old in 2009 is displayed in figure 5.1. Seventy percent of current paediatric patients had a functioning transplant and 30% were reported as being on dialysis.
The treatment modality in use at 90-days following commencement of RRT is displayed in figure 5 .2. This shows that 51% of patients were treated with PD at 90 days whilst 20% of patients were treated with HD. Twenty-two percent of children under 16 were reported to have received a transplant either pre-emptively or by 90 days. Table 5 .4 demonstrates that in the under 2 year olds the majority of patients were being treated with PD (75%). This contrasts with older children in the 12 to 15.99 year age group where 81% had a functioning graft and almost as many people were on HD as PD. Table 5 .5 and figure 5.3 show the diagnostic categories for 635 of 751 current patients aged <16 years for whom a causative diagnosis was reported. Renal dysplasia AE reflux at 34% (216/635) was the commonest condition causing ERF with children commencing RRT across the paediatric age range.
Cause of ERF
Nearly 7% of the current RRT patients have been reported to have developmental delay and an additional 8% with congenital abnormality. Almost 1% other patients have cerebral palsy. Six percent of children receiving RRT were born prematurely (table 5.6). figure 5 .4 show that the reported incidence of RRT has been rising since 1995. Observed incidence rates from one year to the next though are quite unstable because of small numbers. The highest incidence rates are seen in the 12-16 year old age group with the 0-4 year age group having the next highest rates. The average incidence rate per year in 5 year time periods is shown in table 5.8. 
Trends in ERF demographics
Discussion
This report from the Paediatric Renal Registry has focussed on the description of the current demography and the demographic trends over the past 15 years of the UK paediatric ERF population. Over the past few years a sustained effort has been made by the members of the BAPN and the Paediatric RR sub-committee to improve data quality by (i) involving a data manager and a statistician as well as paediatric nephrologists in the team processing the data (ii) merging all available datasets into the larger adult UKRR database and (iii) aiming to have annual returns from all paediatric centres electronically. The benefits of this strategy of electronic data returns are obvious and have been discussed in previous UKRR reports [3, 4] . The recent mandating of reporting to the registry by the Department of Health has helped in implementing this policy locally at individual trusts.
On this background of ongoing 'process transition', 72.6% (569/751) of patients from 8 of 13 paediatric nephrology centres (Birmingham, Bristol, Cardiff, GOSH, Leeds, Manchester Nottingham and Southampton), had their data submitted electronically. Similarly, the merger of paediatric and adult UKRR databases remains as 'work in progress' with incomplete data for the majority of 16-18 year old patients, as they transition variably to adult colleagues across the UK. Further, subjects in this age group may present directly to adult services. Finally, although data for the paediatric ERF population from the UK has been reported pre-1990 [5] it was excluded from this report as it is likely to 
Completeness of data
As shown in table 5.1, completeness of data was >85% for key variables but two particular key data items 'height or length at start of RRT' and 'plasma creatinine at start of RRT' had lower completion rates at 75.3% and 50% respectively. Lack of these values has implications for the quality of any future reports that aim to analyse the impact of RRT on important variables such as growth. Further in this report is the somewhat surprising finding of little change in prevalent comorbidities listed in table 5.13 in children on RRTover the past 15 years. These data perhaps highlight the need for maintaining efforts to improve quality of data returns to and data processing within the UKRR. The authors are optimistic that the commitment of the clinical teams together with improved access to renal IT systems will help to improve data completeness.
Incidence, prevalence and trends As shown in tables 5.7 and 5.8, the incident paediatric ERF population <16 years of age was stable at 9.3 pmarp. This was higher than that reported in the 2009 Registry Report [6] . Reviewing trends in incidence rates over the past 15 years suggests fluctuations from year to [7] the increasing trend in average 5-year incidence rates of children on RRT does not appear to have been reported previously.
Analysis of the incidence rates in 4-year age bands as displayed in table 5.8 suggests this has been maximal in the 12-16 year age band followed by the 0-4 year age band with children less than 2 years old making up the larger proportion of these. A possible explanation for these observed demographic trends is that a greater proportion of children and adolescents <16 years now receive their RRT at paediatric nephrology centres only and that an increasing number of infants and young children are being considered for RRT as a result of improvements in techniques to provide nutritional support and dialysis therapy in this cohort. The increased take on rates in infants contributes significantly to workload as this is a particularly challenging group of patients to manage. A national audit of the care of these infants will provide greater detail.
The prevalence of children on RRT as shown in table 5.2 increased with age in keeping with improved survival with increasing age. This coupled with an increase in the number of children receiving RRT over the past 15 years (table 5.9) has led to a steady increase in the prevalent ERF population. This trend has been observed nationally and across all paediatric nephrology centres (table 5.11). Factors underlying the centre variation seen in the rise in reported patient numbers over time may include variations in the incidence of renal disease related to changes in ethnicity of the local population, changes in referral patterns and variations in the systems in place to support data collection.
Treatment modality of ERF and observed trends 1995-2009
In 2009, the treatment modality at 90 days for peritoneal dialysis was 51%, haemodialysis 20% and transplantation at 22% (figure 5.2). Analysis of these trends in 'modality at 90 days' over the past 15-years is displayed in figure 5 .5 and shows an increase of 4% in patients on haemodialysis (from 19% in 1995-1999 At present it can only be speculated on the reasons for these observations. Some reasons include the increasing incidence of ERF in the youngest patients (<4 years of age) who are commencing RRT (table 5.9) and in whom dialysis often is the only possible modality, increasing incidence in ethnic minorities now commencing RRT (table 5.10) and in whom rates of live-donor transplantation remain low [6] and possible paediatric specific reasons including associated comorbidities, family and social issues for which there is little information but would benefit from more detailed review.
The majority of prevalent children (70%) on RRT have functioning transplants with a steady increase in prevalent children with a functioning transplant seen over the past 15 years (data not shown).
Comorbidities
Informally, paediatric nephrologists report they are managing children with increasingly complex medical problems. It is therefore perhaps surprising to see the relatively low rates of the listed comorbidities reported to the UKRR which have remained stable over time. The small increase in the number of ERF children with liver disease reflects the development of paediatric hepatology and liver transplantation over this time period. The reporting of psychological disorders has decreased but the authors feel this may be related to a lack of consistency in reporting comorbidities to the UKRR. It is difficult to make any comparisons of this data with other national registry reports as there remains no uniformity across registries for reporting and definition of comorbidities [8] .
Causes of ERF and observed trends 1995-2009
Overall, renal dysplasia AE reflux at 34.0%, glomerulonephritis at 16.9% and obstructive uropathy at 16.2% were the commonest listed aetiologies for children with ERF accounting for 67.1% of all patients for whom a primary diagnosis had been reported. Renal dysplasia and obstructive uropathy were both more common in males with a male:female ratio of 2:1 and 16:1 respectively. Observation of trends over the 15-year period showed reduction in ERF secondary to obstructive uropathy (table 5.13), perhaps reflecting improvements in care as a result of early diagnosis and co-ordinated nephro-urological care for these children across the UK. 
